<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39977159</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1606-7916</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>6 (nov-dec)</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>05</Day></PubDate></JournalIssue><Title>Salud publica de Mexico</Title><ISOAbbreviation>Salud Publica Mex</ISOAbbreviation></Journal><ArticleTitle>[Not Available].</ArticleTitle><Pagination><StartPage>788</StartPage><EndPage>797</EndPage><MedlinePgn>788-797</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.21149/15702</ELocationID><Abstract><AbstractText Label="OBJETIVO" NlmCategory="OBJECTIVE">Determinar en pacientes sin seguridad social con diabetes mellitus tipo 2, la prevalencia de enfermedad renal (ER), sus caracter&#xed;sticas cl&#xed;nicas y sociodemogr&#xe1;ficas. Material y m&#xe9;todos. Estudio transversal y anal&#xed;tico, participaron 980 pacientes sin diagn&#xf3;stico de ER de 86 centros de salud. Para la asociaci&#xf3;n de ER con otras variables se utiliz&#xf3; el test de Fisher y la prueba &#x3c7;2 de Pearson; tambi&#xe9;n, se ajust&#xf3; un modelo de regresi&#xf3;n log&#xed;stica ordinal m&#xfa;ltiple.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">La prevalencia de ER fue de 53%, el estadio 2 con 33.98% y 2.76% para los estadios 4-5. Adem&#xe1;s, 75% de los pacientes con hemoglobina glucosilada &#x2265;6.5 y m&#xfa;ltiples comorbilidades. Los factores asociados con ER fueron la edad, proteinuria y consumo de antinflamatorios no esteroideos.</AbstractText><AbstractText Label="CONCLUSIONES" NlmCategory="CONCLUSIONS">El reto del sistema de salud es mejorar las competencias del personal de salud para controlar las enfermedades no transmisibles, realizar diagn&#xf3;stico precoz y brindar atenci&#xf3;n por estadio de ER.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guti&#xe9;rrez-Alba</LastName><ForeName>Gaudencio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Departamento de Sistemas de Salud, Instituto de Ciencias de la Salud, Universidad Veracruzana. Xalapa, Veracruz, M&#xe9;xico.. gagutierrez@uv.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montero-Mora</LastName><ForeName>Judith Guadalupe</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Facultad de Estad&#xed;stica e Inform&#xe1;tica, Universidad Veracruzana. Xalapa, Veracruz, M&#xe9;xico.. jmontero@uv.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guti&#xe9;rrez-Polo</LastName><ForeName>Romana</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Servicios de Salud de Veracruz. Xalapa, Veracruz, M&#xe9;xico.. gutierrezpoloromana@yahoo.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ram&#xed;rez-Cabrera</LastName><ForeName>Jos&#xe9; Bernab&#xe9;</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Centro de Alta Especialidad Dr. Rafael Lucio. Xalapa, Veracruz, M&#xe9;xico.. joseramirez02@uv.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro-Miranda</LastName><ForeName>Benjam&#xed;n</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Centro de Alta Especialidad Dr. Rafael Lucio. Xalapa, Veracruz, M&#xe9;xico.. benjcastro@yahoo.com.mx.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType></PublicationTypeList><VernacularTitle>Enfermedad renal en pacientes mexicanos con diabetes mellitus tipo 2 y sus caracter&#xed;sticas sociodemogr&#xe1;ficas.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Salud Publica Mex</MedlineTA><NlmUniqueID>0404371</NlmUniqueID><ISSNLinking>0036-3634</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008800" MajorTopicYN="N" Type="Geographic">Mexico</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003928" MajorTopicYN="Y">Diabetic Nephropathies</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000091569" MajorTopicYN="N">Sociodemographic Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>20</Day><Hour>18</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>20</Day><Hour>18</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>20</Day><Hour>12</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39977159</ArticleId><ArticleId IdType="doi">10.21149/15702</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38219645</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0534</ISSN><JournalIssue CitedMedium="Internet"><Volume>170</Volume><PubDate><Year>2024</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Computers in biology and medicine</Title><ISOAbbreviation>Comput Biol Med</ISOAbbreviation></Journal><ArticleTitle>Improved predictive diagnosis of diabetic macular edema based on hybrid models: An observational study.</ArticleTitle><Pagination><StartPage>107979</StartPage><MedlinePgn>107979</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.compbiomed.2024.107979</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0010-4825(24)00063-5</ELocationID><Abstract><AbstractText>Diabetic Macular Edema (DME) is the most common sight-threatening complication of type 2 diabetes. Optical Coherence Tomography (OCT) is the most useful imaging technique to diagnose, follow up, and evaluate treatments for DME. However, OCT exam and devices are expensive and unavailable in all clinics in low- and middle-income countries. Our primary goal was therefore to develop an alternative method to OCT for DME diagnosis by introducing spectral information derived from spontaneous electroretinogram (ERG) signals as a single input or combined with fundus that is much more widespread. Baseline ERGs were recorded in 233 patients and transformed into scalograms and spectrograms via Wavelet and Fourier transforms, respectively. Using transfer learning, distinct Convolutional Neural Networks (CNN) were trained as classifiers for DME using OCT, scalogram, spectrogram, and eye fundus images. Input data were randomly split into training and test sets with a proportion of 80 %-20 %, respectively. The top performers for each input type were selected, OpticNet-71 for OCT, DenseNet-201 for eye fundus, and non-evoked ERG-derived scalograms, to generate a combined model by assigning different weights for each of the selected models. Model validation was performed using a dataset alien to the training phase of the models. None of the models powered by mock ERG-derived input performed well. In contrast, hybrid models showed better results, in particular, the model powered by eye fundus combined with mock ERG-derived information with a 91 % AUC and 86 % F1-score, and the model powered by OCT and mock ERG-derived scalogram images with a 93 % AUC and 89 % F1-score. These data show that the spontaneous ERG-derived input adds predictive value to the fundus- and OCT-based models to diagnose DME, except for the sensitivity of the OCT model which remains the same. The inclusion of mock ERG signals, which have recently been shown to take only 5&#xa0;min to record in daylight conditions, therefore represents a potential improvement over existing OCT-based models, as well as a reliable and cost-effective alternative when combined with the fundus, especially in underserved areas, to predict DME.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hughes-Cano</LastName><ForeName>J A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Laboratorio de Investigaci&#xf3;n Traslacional en Salud Visual, Instituto de Neurobiolog&#xed;a, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico (UNAM), Campus Juriquilla, Quer&#xe9;taro, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quiroz-Mercado</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Research Department, Asociaci&#xf3;n Para Evitar la Ceguera, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Zimbr&#xf3;n</LastName><ForeName>L F</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Research Department, Asociaci&#xf3;n Para Evitar la Ceguera, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Franco</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Instituto Mexicano de Oftalmolog&#xed;a (IMO), I.A.P., Circuito Exterior Estadio Corregidora Sn, Centro Sur, 76090 Santiago de Quer&#xe9;taro, Quer&#xe9;taro, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubio Mijangos</LastName><ForeName>J F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Instituto Mexicano de Oftalmolog&#xed;a (IMO), I.A.P., Circuito Exterior Estadio Corregidora Sn, Centro Sur, 76090 Santiago de Quer&#xe9;taro, Quer&#xe9;taro, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Star</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Instituto Mexicano de Oftalmolog&#xed;a (IMO), I.A.P., Circuito Exterior Estadio Corregidora Sn, Centro Sur, 76090 Santiago de Quer&#xe9;taro, Quer&#xe9;taro, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Roa</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Instituto Mexicano de Oftalmolog&#xed;a (IMO), I.A.P., Circuito Exterior Estadio Corregidora Sn, Centro Sur, 76090 Santiago de Quer&#xe9;taro, Quer&#xe9;taro, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lansingh</LastName><ForeName>V C</ForeName><Initials>VC</Initials><AffiliationInfo><Affiliation>Instituto Mexicano de Oftalmolog&#xed;a (IMO), I.A.P., Circuito Exterior Estadio Corregidora Sn, Centro Sur, 76090 Santiago de Quer&#xe9;taro, Quer&#xe9;taro, Mexico; HelpMeSee, Inc., 20 West 36th Street, Floor 4, New York, NY, 10018-8005, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olivares-Pinto</LastName><ForeName>U</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Escuela Nacional de Estudios Superiores Unidad Juriquilla, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico (UNAM), Campus Juriquilla, Quer&#xe9;taro, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Th&#xe9;bault</LastName><ForeName>S C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Laboratorio de Investigaci&#xf3;n Traslacional en Salud Visual, Instituto de Neurobiolog&#xed;a, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico (UNAM), Campus Juriquilla, Quer&#xe9;taro, Mexico. Electronic address: sthebault@comunidad.unam.mx.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Comput Biol Med</MedlineTA><NlmUniqueID>1250250</NlmUniqueID><ISSNLinking>0010-4825</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008269" MajorTopicYN="Y">Macular Edema</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003930" MajorTopicYN="Y">Diabetic Retinopathy</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005654" MajorTopicYN="N">Fundus Oculi</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D041623" MajorTopicYN="N">Tomography, Optical Coherence</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Classifier</Keyword><Keyword MajorTopicYN="N">Hybrid model</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors of this study declare no conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>15</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>14</Day><Hour>18</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38219645</ArticleId><ArticleId IdType="doi">10.1016/j.compbiomed.2024.107979</ArticleId><ArticleId IdType="pii">S0010-4825(24)00063-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36634073</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Preventable risk factors for type 2 diabetes can be detected using noninvasive spontaneous electroretinogram signals.</ArticleTitle><Pagination><StartPage>e0278388</StartPage><MedlinePgn>e0278388</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0278388</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0278388</ELocationID><Abstract><AbstractText>Given the ever-increasing prevalence of type 2 diabetes and obesity, the pressure on global healthcare is expected to be colossal, especially in terms of blindness. Electroretinogram (ERG) has long been perceived as a first-use technique for diagnosing eye diseases, and some studies suggested its use for preventable risk factors of type 2 diabetes and thereby diabetic retinopathy (DR). Here, we show that in a non-evoked mode, ERG signals contain spontaneous oscillations that predict disease cases in rodent models of obesity and in people with overweight, obesity, and metabolic syndrome but not yet diabetes, using one single random forest-based model. Classification performance was both internally and externally validated, and correlation analysis showed that the spontaneous oscillations of the non-evoked ERG are altered before oscillatory potentials, which are the current gold-standard for early DR. Principal component and discriminant analysis suggested that the slow frequency (0.4-0.7 Hz) components are the main discriminators for our predictive model. In addition, we established that the optimal conditions to record these informative signals, are 5-minute duration recordings under daylight conditions, using any ERG sensors, including ones working with portative, non-mydriatic devices. Our study provides an early warning system with promising applications for prevention, monitoring and even the development of new therapies against type 2 diabetes.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Noguez Imm et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Noguez Imm</LastName><ForeName>Rams&#xe9;s</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Instituto de Neurobiolog&#xed;a y Universidad Nacional Aut&#xf3;noma de M&#xe9;xico (UNAM), Campus UNAM-Juriquilla, Quer&#xe9;taro, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu&#xf1;oz-Benitez</LastName><ForeName>Julio</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Facultad de Ingenier&#xed;a, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico (UNAM), Ciudad Universitaria, Ciudad de M&#xe9;xico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medina</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Facultad de Ingenier&#xed;a, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico (UNAM), Ciudad Universitaria, Ciudad de M&#xe9;xico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barcenas</LastName><ForeName>Everardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Facultad de Ingenier&#xed;a, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico (UNAM), Ciudad Universitaria, Ciudad de M&#xe9;xico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molero-Castillo</LastName><ForeName>Guillermo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Facultad de Ingenier&#xed;a, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico (UNAM), Ciudad Universitaria, Ciudad de M&#xe9;xico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyes-Ortega</LastName><ForeName>Pamela</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Instituto de Neurobiolog&#xed;a y Universidad Nacional Aut&#xf3;noma de M&#xe9;xico (UNAM), Campus UNAM-Juriquilla, Quer&#xe9;taro, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes-Cano</LastName><ForeName>Jorge Armando</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Instituto de Neurobiolog&#xed;a y Universidad Nacional Aut&#xf3;noma de M&#xe9;xico (UNAM), Campus UNAM-Juriquilla, Quer&#xe9;taro, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medrano-Gracia</LastName><ForeName>Leticia</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8478-5014</Identifier><AffiliationInfo><Affiliation>IIMAS, Nacional Aut&#xf3;noma de M&#xe9;xico (UNAM), CDMX, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miranda-Anaya</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unidad Multidisciplinaria de Docencia e Investigaci&#xf3;n-Facultad de Ciencias, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico (UNAM), Campus UNAM-Juriquilla, Quer&#xe9;taro, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas-Piloni</LastName><ForeName>Gerardo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Instituto de Neurobiolog&#xed;a y Universidad Nacional Aut&#xf3;noma de M&#xe9;xico (UNAM), Campus UNAM-Juriquilla, Quer&#xe9;taro, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quiroz-Mercado</LastName><ForeName>Hugo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Research Department, Asociaci&#xf3;n Para Evitar la Ceguera, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Zimbr&#xf3;n</LastName><ForeName>Luis Fernando</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Research Department, Asociaci&#xf3;n Para Evitar la Ceguera, Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cl&#xed;nica de Salud Visual, Escuela Nacional de Estudios Superiores, Unidad Le&#xf3;n, Universidad Nacional Auton&#xf3;ma de M&#xe9;xico (UNAM), Le&#xf3;n, Guanajuato, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fajardo-Cruz</LastName><ForeName>Elisa Denisse</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Research Department, Asociaci&#xf3;n Para Evitar la Ceguera, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreyra-Severo</LastName><ForeName>Ezequiel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Research Department, Asociaci&#xf3;n Para Evitar la Ceguera, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Franco</LastName><ForeName>Renata</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Instituto de la Retina del Baj&#xed;o (INDEREB), Prolongaci&#xf3;n Constituyentes 302 (Consultorios 410 y 411, torre 3, Hospital San Jos&#xe9;), El jacal, Santiago de Quer&#xe9;taro, Quer&#xe9;taro, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubio Mijangos</LastName><ForeName>Juan Fernando</ForeName><Initials>JF</Initials><Identifier Source="ORCID">0000-0003-3853-1934</Identifier><AffiliationInfo><Affiliation>Instituto Mexicano de Oftalmolog&#xed;a (IMO), I.A.P., Circuito Exterior Estadio Corregidora Sn, Centro Sur, Santiago de Quer&#xe9;taro, Quer&#xe9;taro, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Star</LastName><ForeName>Ellery</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Instituto Mexicano de Oftalmolog&#xed;a (IMO), I.A.P., Circuito Exterior Estadio Corregidora Sn, Centro Sur, Santiago de Quer&#xe9;taro, Quer&#xe9;taro, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Roa</LastName><ForeName>Marlon</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1970-799X</Identifier><AffiliationInfo><Affiliation>Instituto Mexicano de Oftalmolog&#xed;a (IMO), I.A.P., Circuito Exterior Estadio Corregidora Sn, Centro Sur, Santiago de Quer&#xe9;taro, Quer&#xe9;taro, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lansingh</LastName><ForeName>Van Charles</ForeName><Initials>VC</Initials><AffiliationInfo><Affiliation>Instituto Mexicano de Oftalmolog&#xed;a (IMO), I.A.P., Circuito Exterior Estadio Corregidora Sn, Centro Sur, Santiago de Quer&#xe9;taro, Quer&#xe9;taro, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Th&#xe9;bault</LastName><ForeName>St&#xe9;phanie C</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0003-3233-282X</Identifier><AffiliationInfo><Affiliation>Instituto de Neurobiolog&#xed;a y Universidad Nacional Aut&#xf3;noma de M&#xe9;xico (UNAM), Campus UNAM-Juriquilla, Quer&#xe9;taro, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004596" MajorTopicYN="N">Electroretinography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003930" MajorTopicYN="Y">Diabetic Retinopathy</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>12</Day><Hour>13</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36634073</ArticleId><ArticleId IdType="pmc">PMC9836271</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0278388</ArticleId><ArticleId IdType="pii">PONE-D-22-22890</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stem MS, Gardner TW, Comer GM. 42: Management of Diabetic Retinopathy. ADA. Therapy for Diabetes Mellitus and Related Disorders. ADA. 2014.</Citation></Reference><Reference><Citation>Das T, Takkar B, Sivaprasad S, Thanksphon T, Taylor H, Wiedemann P, et al. Recently updated global diabetic retinopathy screening guidelines: commonalities, differences, and future possibilities. Eye. 2021;35: 2685&#x2013;2698. doi: 10.1038/s41433-021-01572-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41433-021-01572-4</ArticleId><ArticleId IdType="pmc">PMC8452707</ArticleId><ArticleId IdType="pubmed">33976399</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawlor MS, Blackwell CS, Isom SP, Katula JA, Vitolins MZ, Morgan TM, et al. Cost of a group translation of the diabetes prevention program: Healthy living partnerships to prevent diabetes. American Journal of Preventive Medicine. 2013;44: S381&#x2013;S389. doi: 10.1016/j.amepre.2012.12.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2012.12.016</ArticleId><ArticleId IdType="pmc">PMC3839056</ArticleId><ArticleId IdType="pubmed">23498303</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Mozaffarian D, Sy S, Lee Y, Wilde PE, Abrahams-Gessel S, et al. Health and Economic Impacts of the National Menu Calorie Labeling Law in the United States: A Microsimulation Study. Circulation: Cardiovascular Quality and Outcomes. 2020;13: 309&#x2013;319. doi: 10.1161/CIRCOUTCOMES.119.006313</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.119.006313</ArticleId><ArticleId IdType="pmc">PMC7299757</ArticleId><ArticleId IdType="pubmed">32493057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur G, Lakshmi PVM, Rastogi A, Bhansali A, Jain S, Teerawattananon Y, et al. Diagnostic accuracy of tests for type 2 diabetes and prediabetes: A systematic review and meta-analysis. Atkin SL, editor. PLOS ONE. 2020;15: e0242415. doi: 10.1371/journal.pone.0242415</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0242415</ArticleId><ArticleId IdType="pmc">PMC7678987</ArticleId><ArticleId IdType="pubmed">33216783</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanaya AM, Venkat Narayan KM. Prevention of type 2 diabetes: Data from recent trials. Primary Care&#x2014;Clinics in Office Practice. W.B. Saunders; 2003. pp. 511&#x2013;526. doi: 10.1016/S0095-4543(03)00034-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0095-4543(03)00034-4</ArticleId><ArticleId IdType="pubmed">14692198</ArticleId></ArticleIdList></Reference><Reference><Citation>Group TA to CCR in DS. Effects of Intensive Glucose Lowering in Type 2 Diabetes. New England Journal of Medicine. 2008;358: 2545&#x2013;2559. doi: 10.1056/NEJMoa0802743</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0802743</ArticleId><ArticleId IdType="pmc">PMC4551392</ArticleId><ArticleId IdType="pubmed">18539917</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceriello A, Monnier L, Owens D. Glycaemic variability in diabetes: clinical and therapeutic implications. The Lancet Diabetes and Endocrinology. Lancet Publishing Group; 2019. pp. 221&#x2013;230. doi: 10.1016/S2213-8587(18)30136-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(18)30136-0</ArticleId><ArticleId IdType="pubmed">30115599</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzs&#xe1;ki G, Draguhn A. Neuronal olscillations in cortical networks. Science. Science; 2004. pp. 1926&#x2013;1929. doi: 10.1126/science.1099745</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1099745</ArticleId><ArticleId IdType="pubmed">15218136</ArticleId></ArticleIdList></Reference><Reference><Citation>Behar-Cohen F, Loewenstein A. Current and Future Treatments for Diabetic Retinopathy. Pharmaceutics. 2022;14: 812. doi: 10.3390/pharmaceutics14040812</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics14040812</ArticleId><ArticleId IdType="pmc">PMC9026793</ArticleId><ArticleId IdType="pubmed">35456647</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyllienmark L, Maltez J, Dandenell A, Ludvigsson J, Brismar T. EEG abnormalities with and without relation to severe hypoglycaemia in adolescents with type 1 diabetes. Diabetologia. 2005;48: 412&#x2013;419. doi: 10.1007/s00125-004-1666-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-004-1666-2</ArticleId><ArticleId IdType="pubmed">15739116</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeighami Y, Iceta S, Dadar M, Pelletier M, Nadeau M, Biertho L, et al. Spontaneous neural activity changes after bariatric surgery: A resting-state fMRI study. Neuroimage. 2021;241. doi: 10.1016/j.neuroimage.2021.118419</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2021.118419</ArticleId><ArticleId IdType="pubmed">34302967</ArticleId></ArticleIdList></Reference><Reference><Citation>Biehl SC, Keil J, Naumann E, Svaldi J. ERP and oscillatory differences in overweight/obese and normal-weight adolescents in response to food stimuli. Journal of Eating Disorders. 2020;8: 14. doi: 10.1186/s40337-020-00290-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40337-020-00290-8</ArticleId><ArticleId IdType="pmc">PMC7137417</ArticleId><ArticleId IdType="pubmed">32280464</ArticleId></ArticleIdList></Reference><Reference><Citation>Tammela LI, P&#xe4;&#xe4;kk&#xf6;nen A, Karhunen LJ, Karhu J, Uusitupa MIJ, Kuikka JT. Brain electrical activity during food presentation in obese binge-eating women. Clinical Physiology and Functional Imaging. 2010;30: 135&#x2013;140. doi: 10.1111/j.1475-097X.2009.00916.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1475-097X.2009.00916.x</ArticleId><ArticleId IdType="pubmed">20095978</ArticleId></ArticleIdList></Reference><Reference><Citation>Imperatori C, Fabbricatore M, Innamorati M, Farina B, Quintiliani MI, Lamis DA, et al. Modification of EEG functional connectivity and EEG power spectra in overweight and obese patients with food addiction: An eLORETA study. Brain Imaging and Behavior. 2015;9: 703&#x2013;716. doi: 10.1007/s11682-014-9324-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11682-014-9324-x</ArticleId><ArticleId IdType="pubmed">25332109</ArticleId></ArticleIdList></Reference><Reference><Citation>Baver SB, Hope K, Guyot S, Bj&#xf8;rbaek C, Kaczorowski C, O&#x2019;Connell KMS. Leptin modulates the intrinsic excitability of AgRP/NPY neurons in the arcuate nucleus of the hypothalamus. Journal of Neuroscience. 2014;34: 5486&#x2013;5496. doi: 10.1523/JNEUROSCI.4861-12.2014</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4861-12.2014</ArticleId><ArticleId IdType="pmc">PMC4298648</ArticleId><ArticleId IdType="pubmed">24741039</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang JJ, Gao F, Wu SM. Light-evoked excitatory and inhibitory synaptic inputs to ON and OFF &#x3b1; ganglion cells in the mouse retina. Journal of Neuroscience. 2003;23: 6063&#x2013;6073. doi: 10.1523/jneurosci.23-14-06063.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.23-14-06063.2003</ArticleId><ArticleId IdType="pmc">PMC6740343</ArticleId><ArticleId IdType="pubmed">12853425</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy GJ, Rieke F. Network Variability Limits Stimulus-Evoked Spike Timing Precision in Retinal Ganglion Cells. Neuron. 2006;52: 511&#x2013;524. doi: 10.1016/j.neuron.2006.09.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.09.014</ArticleId><ArticleId IdType="pmc">PMC2032021</ArticleId><ArticleId IdType="pubmed">17088216</ArticleId></ArticleIdList></Reference><Reference><Citation>Margolis DJ, Detwiler PB. Different mechanisms generate maintained activity in ON and OFF retinal ganglion cells. Journal of Neuroscience. 2007;27: 5994&#x2013;6005. doi: 10.1523/JNEUROSCI.0130-07.2007</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0130-07.2007</ArticleId><ArticleId IdType="pmc">PMC3136104</ArticleId><ArticleId IdType="pubmed">17537971</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuffler SW. Discharge patterns and functional organization of mammalian retina. J Neurophysiol. 1953;16: 37&#x2013;68. doi: 10.1152/jn.1953.16.1.37</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.1953.16.1.37</ArticleId><ArticleId IdType="pubmed">13035466</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinberg RH. Oscillatory activity in the optic tract of cat and light adaptation. J Neurophysiol. 1966;29: 139&#x2013;156. doi: 10.1152/jn.1966.29.2.139</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.1966.29.2.139</ArticleId><ArticleId IdType="pubmed">5927454</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuenschwander S, Castelo-Branco M, Singer W. Synchronous oscillations in the cat retina. Vision Research. 1999. doi: 10.1016/s0042-6989(99)00042-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0042-6989(99)00042-5</ArticleId><ArticleId IdType="pubmed">10396618</ArticleId></ArticleIdList></Reference><Reference><Citation>Petit-Jacques J, V&#xf6;lgyi B, Rudy B, Bloomfield S. Spontaneous oscillatory activity of starburst amacrine cells in the mouse retina. Journal of Neurophysiology. 2005;94: 1770&#x2013;1780. doi: 10.1152/jn.00279.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00279.2005</ArticleId><ArticleId IdType="pubmed">15917322</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrone J, Lagnado L. Electrical resonance and Ca2+ influx in the synaptic terminal of depolarizing bipolar cells from the goldfish retina. Journal of Physiology. 1997. doi: 10.1111/j.1469-7793.1997.571ba.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-7793.1997.571ba.x</ArticleId><ArticleId IdType="pmc">PMC1160036</ArticleId><ArticleId IdType="pubmed">9457636</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y-P, Pan Z-H. Spontaneous regenerative activity in mammalian retinal bipolar cells: roles of multiple subtypes of voltage-dependent {Ca2}+ channels. Visual Neuroscience. 2003;20: 131&#x2013;139. doi: 10.1017/s0952523803202042</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0952523803202042</ArticleId><ArticleId IdType="pubmed">12916735</ArticleId></ArticleIdList></Reference><Reference><Citation>Solessio E, Vigh J, Cuenca N, Rapp K, Lasater EM. Membrane properties of an unusual intrinsically oscillating, wide&#x2010;field teleost retinal amacrine cell. The Journal of Physiology. 2002;544: 831&#x2013;847. doi: 10.1113/jphysiol.2002.021899</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2002.021899</ArticleId><ArticleId IdType="pmc">PMC2290642</ArticleId><ArticleId IdType="pubmed">12411527</ArticleId></ArticleIdList></Reference><Reference><Citation>Feigenspan A, Gustincich S, Bean BP, Raviola E. Spontaneous activity of solitary dopaminergic cells of the retina. Journal of Neuroscience. 1998;18: 6776&#x2013;6789. doi: 10.1523/JNEUROSCI.18-17-06776.1998</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.18-17-06776.1998</ArticleId><ArticleId IdType="pmc">PMC6792954</ArticleId><ArticleId IdType="pubmed">9712649</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews BHC. Sensory Mechanisms of the Retina. Nature. 1949;163: 423&#x2013;424. doi: 10.1038/163423a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/163423a0</ArticleId></ArticleIdList></Reference><Reference><Citation>Yee CW, Toychiev AH, Sagdullaev BT. Network deficiency exacerbates impairment in a mouse model of retinal degeneration. Frontiers in Systems Neuroscience. 2012;6: 8. doi: 10.3389/fnsys.2012.00008</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnsys.2012.00008</ArticleId><ArticleId IdType="pmc">PMC3285818</ArticleId><ArticleId IdType="pubmed">22383900</ArticleId></ArticleIdList></Reference><Reference><Citation>Trenholm S, Awatramani GB. Origins of spontaneous activity in the degenerating retina. Frontiers in Cellular Neuroscience. 2015;9: 277. doi: 10.3389/fncel.2015.00277</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00277</ArticleId><ArticleId IdType="pmc">PMC4518194</ArticleId><ArticleId IdType="pubmed">26283914</ArticleId></ArticleIdList></Reference><Reference><Citation>Goo YS, Park DJ, Ahn JR, Senok SS. Spontaneous Oscillatory Rhythms in the Degenerating Mouse Retina Modulate Retinal Ganglion Cell Responses to Electrical Stimulation. Frontiers in Cellular Neuroscience. 2016;9: 512. doi: 10.3389/fncel.2015.00512</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00512</ArticleId><ArticleId IdType="pmc">PMC4709854</ArticleId><ArticleId IdType="pubmed">26793063</ArticleId></ArticleIdList></Reference><Reference><Citation>Euler T, Schubert T. Multiple Independent Oscillatory Networks in the Degenerating Retina. Frontiers in Cellular Neuroscience. 2015;9: 444. doi: 10.3389/fncel.2015.00444</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00444</ArticleId><ArticleId IdType="pmc">PMC4637421</ArticleId><ArticleId IdType="pubmed">26617491</ArticleId></ArticleIdList></Reference><Reference><Citation>Eggers ED, Carreon TA. The effects of early diabetes on inner retinal neurons. Visual Neuroscience. Cambridge University Press; 2020. doi: 10.1017/S095252382000005X</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S095252382000005X</ArticleId><ArticleId IdType="pmc">PMC7503216</ArticleId><ArticleId IdType="pubmed">32933604</ArticleId></ArticleIdList></Reference><Reference><Citation>Robson AG, Nilsson J, Li S, Jalali S, Fulton AB, Tormene AP, et al. {ISCEV} guide to visual electrodiagnostic procedures. Documenta Ophthalmologica Advances in Ophthalmology. 2018;136: 1&#x2013;26. doi: 10.1007/s10633-017-9621-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10633-017-9621-y</ArticleId><ArticleId IdType="pmc">PMC5811581</ArticleId><ArticleId IdType="pubmed">29397523</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato K, Kondo M, Sugimoto M, Ikesugi K, Matsubara H. Effect of pupil size on flicker ERGs recorded with RETeval system: New mydriasis-free full-field ERG system. Investigative Ophthalmology and Visual Science. 2015;56: 3684&#x2013;3690. doi: 10.1167/iovs.14-16349</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.14-16349</ArticleId><ArticleId IdType="pubmed">26047169</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda-Anaya M, P&#xe9;rez-Mendoza M, Ju&#xe1;rez-Tapia CR, Carmona-Castro A. The volcano mouse {Neotomodon} alstoni of central {Mexico}, a biological model in the study of breeding, obesity and circadian rhythms. General and Comparative Endocrinology. 2019;273: 61&#x2013;66. doi: 10.1016/j.ygcen.2018.04.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygcen.2018.04.024</ArticleId><ArticleId IdType="pubmed">29702105</ArticleId></ArticleIdList></Reference><Reference><Citation>Like AA, Rossini AA. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science. 1976;193: 415&#x2013;417. doi: 10.1126/science.180605</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.180605</ArticleId><ArticleId IdType="pubmed">180605</ArticleId></ArticleIdList></Reference><Reference><Citation>King AJF. The use of animal models in diabetes research. British Journal of Pharmacology. 2012;166: 877&#x2013;894. doi: 10.1111/j.1476-5381.2012.01911.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.2012.01911.x</ArticleId><ArticleId IdType="pmc">PMC3417415</ArticleId><ArticleId IdType="pubmed">22352879</ArticleId></ArticleIdList></Reference><Reference><Citation>Han BG, Hao C-M, Tchekneva EE, Wang Y-Y, Lee CA, Ebrahim B, et al. Markers of glycemic control in the mouse: comparisons of 6-h- and overnight-fasted blood glucoses to {Hb} {A1c}. American Journal of Physiology Endocrinology and Metabolism. 2008;295: E981&#x2014;986. doi: 10.1152/ajpendo.90283.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.90283.2008</ArticleId><ArticleId IdType="pmc">PMC2575908</ArticleId><ArticleId IdType="pubmed">18664598</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagdullaev B., DeMarco P. &amp; McCall M.
Improved contact lens electrode for corneal ERG recordings in mice.
<i>Doc Ophthalmol</i>
108, 181&#x2013;184 (2004). doi: 10.1007/s10633-004-5734-1
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10633-004-5734-1</ArticleId><ArticleId IdType="pubmed">15573941</ArticleId></ArticleIdList></Reference><Reference><Citation>Armington JC. Electroretinogram, {Electroretinography}. In: Held R, editor. Sensory {System} {I}: {Vision} and {Visual} {Systems}. Boston, MA: Birkh&#xe4;user; 1988. pp. 21&#x2013;22. doi: 10.1007/978-1-4899-6647-6_11</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4899-6647-6_11</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28: 412&#x2013;419. doi: 10.1007/BF00280883</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00280883</ArticleId><ArticleId IdType="pubmed">3899825</ArticleId></ArticleIdList></Reference><Reference><Citation>Global report on diabetes. World Health Organization. 2016. ISBN: 9789241565257</Citation></Reference><Reference><Citation>Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. {Part} 1: diagnosis and classification of diabetes mellitus provisional report of a {WHO} consultation. Diabetic Medicine: A Journal of the British Diabetic Association. 1998;15: 539&#x2013;553. doi: 10.1002/(SICI)1096-9136(199807)15:7&amp;lt;539::AID-DIA668&amp;gt;3.0.CO;2-S</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9136(199807)15:7&amp;lt;539::AID-DIA668&amp;gt;3.0.CO;2-S</ArticleId><ArticleId IdType="pubmed">9686693</ArticleId></ArticleIdList></Reference><Reference><Citation>The IDF consensus worldwide definition of the metabolic s&#xed;ndrome. International Diabetes Federation. E-library, published in 2006, last update 2020.</Citation></Reference><Reference><Citation>Nwagha UI, Ikekpeazu EJ, Ejezie FE, Neboh EE, Maduka IC. Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in {Enugu}, {Nigeria}. African Health Sciences. 2010;10: 248&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3035958</ArticleId><ArticleId IdType="pubmed">21327136</ArticleId></ArticleIdList></Reference><Reference><Citation>Robson AG, Frishman LJ, Grigg J, Hamilton R, Jeffrey BG, Kondo M, et al. ISCEV Standard for full-field clinical electroretinography (2022 update). Documenta Ophthalmologica. 2022. [cited 24 May 2022]. doi: 10.1007/s10633-022-09872-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10633-022-09872-0</ArticleId><ArticleId IdType="pmc">PMC9192408</ArticleId><ArticleId IdType="pubmed">35511377</ArticleId></ArticleIdList></Reference><Reference><Citation>Brigell MG, Chiang B, Maa AY, Quentin Davis C. Enhancing risk assessment in patients with diabetic retinopathy by combining measures of retinal function and structure. Translational Vision Science and Technology. 2020;9: 1&#x2013;9. doi: 10.1167/tvst.9.9.40</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/tvst.9.9.40</ArticleId><ArticleId IdType="pmc">PMC7453041</ArticleId><ArticleId IdType="pubmed">32908803</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Y, Cao D, Yang D, Zhuang X, Yu H, Hu Y, et al. Screening for diabetic retinopathy in diabetic patients with a mydriasis-free, full-field flicker electroretinogram recording device. Documenta Ophthalmologica Advances in Ophthalmology. 2020;140: 211&#x2013;220. doi: 10.1007/s10633-019-09734-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10633-019-09734-2</ArticleId><ArticleId IdType="pubmed">31720980</ArticleId></ArticleIdList></Reference><Reference><Citation>Oostenveld R, Fries P, Maris E, Schoffelen J-M. {FieldTrip}: {Open} source software for advanced analysis of {MEG}, {EEG}, and invasive electrophysiological data. Computational Intelligence and Neuroscience. 2011;2011: 156869. doi: 10.1155/2011/156869</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/156869</ArticleId><ArticleId IdType="pmc">PMC3021840</ArticleId><ArticleId IdType="pubmed">21253357</ArticleId></ArticleIdList></Reference><Reference><Citation>DeVries PMR, Vi&#xe9;gas F, Wattenberg M, Meade BJ. Deep learning of aftershock patterns following large earthquakes. Nature. 2018;560: 632&#x2013;634. doi: 10.1038/s41586-018-0438-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0438-y</ArticleId><ArticleId IdType="pubmed">30158606</ArticleId></ArticleIdList></Reference><Reference><Citation>Provost F, Fawcett T, Kohavi R. The {Case} {Against} {Accuracy} {Estimation} for {Comparing} {Induction} {Algorithms}. In {Proceedings} of the {Fifteenth} {International} {Conference} on {Machine} {Learning}. Morgan Kaufmann; 1998. pp. 445&#x2013;453.</Citation></Reference><Reference><Citation>Yijia Z, Hongfei L, Zhihao Y, Jian W, Yuanyuan S, Bo X, et al. Neural network-based approaches for biomedical relation classification: A review. J Biomed Inform. 2019. Nov;99:103294. doi: 10.1016/j.jbi.2019.103294</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103294</ArticleId><ArticleId IdType="pubmed">31557530</ArticleId></ArticleIdList></Reference><Reference><Citation>Dankers FJWM, Traverso A, Wee L, van Kuijk SMJ. Prediction {Modeling} {Methodology}. In: Kubben P, Dumontier M, Dekker A, editors. Fundamentals of {Clinical} {Data} {Science}. Cham (CH): Springer; 2019. Available: http://www.ncbi.nlm.nih.gov/books/NBK543534/</Citation><ArticleIdList><ArticleId IdType="pubmed">31314250</ArticleId></ArticleIdList></Reference><Reference><Citation>Midena E, Torresin T, Longhin E, Midena G, Pilotto E, Frizziero L. Early Microvascular and Oscillatory Potentials Changes in Human Diabetic Retina: Amacrine Cells and the Intraretinal Neurovascular Crosstalk. Journal of Clinical Medicine. 2021;10: 4035. doi: 10.3390/jcm10184035</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10184035</ArticleId><ArticleId IdType="pmc">PMC8466765</ArticleId><ArticleId IdType="pubmed">34575150</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinilla I, Idoipe M, Perdices L, Sanchez-Cano A, Acha J, Lopez-Galvez MI, et al. Changes in total and inner retinal thicknesses in type 1 diabetes with no retinopathy after 8 years of follow-up. Retina. 2020;40: 1379&#x2013;1386. doi: 10.1097/IAE.0000000000002576</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/IAE.0000000000002576</ArticleId><ArticleId IdType="pubmed">31157712</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitale PM, Gorbatyuk MS. Diabetic Retinopathy: From Animal Models to Cellular Signaling. International Journal of Molecular Sciences. 2022;23: 1487. doi: 10.3390/ijms23031487</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031487</ArticleId><ArticleId IdType="pmc">PMC8835767</ArticleId><ArticleId IdType="pubmed">35163410</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan WM, Al-Dbass A, Al-Ayadhi L, Bhat RS, El-Ansary A. Discriminant analysis and binary logistic regression enable more accurate prediction of autism spectrum disorder than principal component analysis. Scientific Reports. 2022;12: 1&#x2013;13. doi: 10.1038/s41598-022-07829-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-07829-6</ArticleId><ArticleId IdType="pmc">PMC8904630</ArticleId><ArticleId IdType="pubmed">35260688</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan A, Lee AY. Artificial intelligence deployment in diabetic retinopathy: the last step of the translation continuum. The Lancet Digital Health. Elsevier Ltd; 2022. pp. e208&#x2013;e209. doi: 10.1016/S2589-7500(22)00027-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(22)00027-9</ArticleId><ArticleId IdType="pubmed">35272973</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathenge W, Whitestone N, Nkurikiye J, Patnaik JL, Piyasena P, Uwaliraye P, et al. Impact of artificial intelligence assessment of diabetic retinopathy on referral service uptake in a low resource setting: The RAIDERS randomized trial. Ophthalmology Science. 2022; 100168. doi: 10.1016/j.xops.2022.100168</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xops.2022.100168</ArticleId><ArticleId IdType="pmc">PMC9754978</ArticleId><ArticleId IdType="pubmed">36531575</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang H. Development and Validation of a Patient Self-assessment Score for Diabetes Risk. Annals of Internal Medicine. 2009;151: 775. doi: 10.7326/0003-4819-151-11-200912010-00005</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-151-11-200912010-00005</ArticleId><ArticleId IdType="pmc">PMC3633111</ArticleId><ArticleId IdType="pubmed">19949143</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Mart&#xed;nez P, Mikhailidis DP, Athyros VG, Bullo M, Couture P, Covas MI, et al. Lifestyle recommendations for the prevention and management of metabolic syndrome: An international panel recommendation. Nutrition Reviews. 2017;75: 307&#x2013;326. doi: 10.1093/nutrit/nux014</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nutrit/nux014</ArticleId><ArticleId IdType="pmc">PMC5914407</ArticleId><ArticleId IdType="pubmed">28521334</ArticleId></ArticleIdList></Reference><Reference><Citation>Pluta W, Dudzi&#x144;ska W, Lubkowska A. Metabolic Obesity in People with Normal Body Weight (MONW)&#x2014;Review of Diagnostic Criteria. International Journal of Environmental Research and Public Health. MDPI; 2022. doi: 10.3390/ijerph19020624</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19020624</ArticleId><ArticleId IdType="pmc">PMC8776153</ArticleId><ArticleId IdType="pubmed">35055447</ArticleId></ArticleIdList></Reference><Reference><Citation>Bl&#xfc;her M. Metabolically healthy obesity. Endocrine Reviews. Endocrine Society; 2020. pp. 405&#x2013;420. doi: 10.1210/endrev/bnaa004</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endrev/bnaa004</ArticleId><ArticleId IdType="pmc">PMC7098708</ArticleId><ArticleId IdType="pubmed">32128581</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim&#xf3; R, Stitt AW, Gardner TW. Neurodegeneration in diabetic retinopathy: does it really matter? Diabetologia. 2018;61: 1902&#x2013;1912. doi: 10.1007/s00125-018-4692-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-018-4692-1</ArticleId><ArticleId IdType="pmc">PMC6096638</ArticleId><ArticleId IdType="pubmed">30030554</ArticleId></ArticleIdList></Reference><Reference><Citation>Keeling E, Lynn SA, Koh YM, Scott JA, Kendall A, Gatherer M, et al. A High Fat &#x201c;Western&#x2010;style&#x201d; Diet Induces AMD&#x2010;like Features in Wildtype Mice. Molecular Nutrition &amp; Food Research. 2022; 2100823. doi: 10.1002/mnfr.202100823</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.202100823</ArticleId><ArticleId IdType="pmc">PMC9287010</ArticleId><ArticleId IdType="pubmed">35306732</ArticleId></ArticleIdList></Reference><Reference><Citation>Asare-Bediako B, Noothi S, Li Calzi S, Athmanathan B, Vieira C, Adu-Agyeiwaah Y, et al. Characterizing the Retinal Phenotype in the High-Fat Diet and Western Diet Mouse Models of Prediabetes. Cells. 2020;9: 464. doi: 10.3390/cells9020464</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9020464</ArticleId><ArticleId IdType="pmc">PMC7072836</ArticleId><ArticleId IdType="pubmed">32085589</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajagopal R, Bligard GW, Zhang S, Yin L, Lukasiewicz P, Semenkovich CF. Functional deficits precede structural lesions in mice with high-fat diet-induced diabetic retinopathy. Diabetes. 2016;65: 1072&#x2013;1084. doi: 10.2337/db15-1255</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db15-1255</ArticleId><ArticleId IdType="pmc">PMC5166563</ArticleId><ArticleId IdType="pubmed">26740595</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee VK, Hosking BM, Holeniewska J, Kubala EC, Lundh von Leithner P, Gardner PJ, et al. BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changes. Diabetologia. 2018;61: 2422&#x2013;2432. doi: 10.1007/s00125-018-4696-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-018-4696-x</ArticleId><ArticleId IdType="pmc">PMC6182653</ArticleId><ArticleId IdType="pubmed">30094465</ArticleId></ArticleIdList></Reference><Reference><Citation>Buettner R, Sch&#xf6;lmerich J, Bollheimer LC. High-fat diets: Modeling the metabolic disorders of human obesity in rodents. Obesity. Obesity (Silver Spring); 2007. pp. 798&#x2013;808. doi: 10.1038/oby.2007.608</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/oby.2007.608</ArticleId><ArticleId IdType="pubmed">17426312</ArticleId></ArticleIdList></Reference><Reference><Citation>Erkaymaz O, Senyer Yapici &#xcd;, Uzun Arslan R. Effects of obesity on time-frequency components of electroretinogram signal using continuous wavelet transform. Biomedical Signal Processing and Control. 2021;66: 102398. doi: 10.1016/j.bspc.2020.102398</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bspc.2020.102398</ArticleId></ArticleIdList></Reference><Reference><Citation>Yapici &#x130;S, Erkaymaz O, Arslan RU. A hybrid intelligent classifier to estimate obesity levels based on ERG signals. Physics Letters, Section A: General, Atomic and Solid State Physics. 2021;399: 127281. doi: 10.1016/j.physleta.2021.127281</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.physleta.2021.127281</ArticleId></ArticleIdList></Reference><Reference><Citation>Wachtmeister L. Oscillatory potentials in the retina: What do they reveal. Progress in Retinal and Eye Research. 1998;17: 485&#x2013;521. doi: 10.1016/s1350-9462(98)00006-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1350-9462(98)00006-8</ArticleId><ArticleId IdType="pubmed">9777648</ArticleId></ArticleIdList></Reference><Reference><Citation>Zelano C, Jiang H, Zhou G, Arora N, Schuele S, Rosenow J, et al. Nasal respiration entrains human limbic oscillations and modulates cognitive function. Journal of Neuroscience. 2016;36: 12448&#x2013;12467. doi: 10.1523/JNEUROSCI.2586-16.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2586-16.2016</ArticleId><ArticleId IdType="pmc">PMC5148230</ArticleId><ArticleId IdType="pubmed">27927961</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K, Atsumi Y. Precise Measurement of Individual Rapid Eye Movements in REM Sleep of Humans. Sleep. 1997;20: 743&#x2013;752. doi: 10.1093/sleep/20.9.743</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/20.9.743</ArticleId><ArticleId IdType="pubmed">9406327</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason JW, Ramseth DJ, Chanter DO, Moon TE, Goodman DB, Mendzelevski B. Electrocardiographic reference ranges derived from 79,743 ambulatory subjects. Journal of Electrocardiology. 2007;40: 228&#x2013;234.e8. doi: 10.1016/j.jelectrocard.2006.09.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jelectrocard.2006.09.003</ArticleId><ArticleId IdType="pubmed">17276451</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair G, Kim M, Nagaoka T, Olson DE, Thul&#xe9; PM, Pardue MT, et al. Effects of common anesthetics on eye movement and electroretinogram. Documenta Ophthalmologica. 2011;122: 163&#x2013;176. doi: 10.1007/s10633-011-9271-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10633-011-9271-4</ArticleId><ArticleId IdType="pmc">PMC3154733</ArticleId><ArticleId IdType="pubmed">21519880</ArticleId></ArticleIdList></Reference><Reference><Citation>Zenisek D, Matthews G. Calcium action potentials in retinal bipolar neurons. Visual Neuroscience. 1998;15: 69&#x2013;75. doi: 10.1017/s0952523898151064</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0952523898151064</ArticleId><ArticleId IdType="pubmed">9456506</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigh J, Solessio E, Morgans CW, Lasater EM. Ionic mechanisms mediating oscillatory membrane potentials in wide-field retinal amacrine cells. Journal of Neurophysiology. 2003;90: 431&#x2013;443. doi: 10.1152/jn.00092.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00092.2003</ArticleId><ArticleId IdType="pubmed">12649310</ArticleId></ArticleIdList></Reference><Reference><Citation>Trenholm S, Awatramani GB. Myriad roles for gap junctions in retinal circuits. Webvision: The Organization of the Retina and Visual System. University of Utah Health Sciences Center; 1995. Available: http://www.ncbi.nlm.nih.gov/pubmed/31765113</Citation><ArticleIdList><ArticleId IdType="pubmed">31765113</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutcheon B, Yarom Y. Resonance, oscillation and the intrinsic frequency preferences of neurons. Trends in Neurosciences. Elsevier Ltd; 2000. pp. 216&#x2013;222. doi: 10.1016/s0166-2236(00)01547-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0166-2236(00)01547-2</ArticleId><ArticleId IdType="pubmed">10782127</ArticleId></ArticleIdList></Reference><Reference><Citation>Calbiague VM, Vielma AH, Cadiz B, Paquet&#x2010;Durand F, Schmachtenberg O. Physiological assessment of high glucose neurotoxicity in mouse and rat retinal explants. Journal of Comparative Neurology. 2020;528: 989&#x2013;1002. doi: 10.1002/cne.24805</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.24805</ArticleId><ArticleId IdType="pubmed">31674018</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura C, Kuriyama K. Alterations in the Retinal Dopaminergic Neuronal System in Rats with Streptozotocin-Induced Diabetes. Journal of Neurochemistry. 1985;45: 448&#x2013;455. doi: 10.1111/j.1471-4159.1985.tb04008.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1985.tb04008.x</ArticleId><ArticleId IdType="pubmed">3925083</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore-Dotson JM, Eggers ED. Reductions in calcium signaling limit inhibition to diabetic retinal rod bipolar cells. Investigative Ophthalmology and Visual Science. 2019;60: 4063&#x2013;4073. doi: 10.1167/iovs.19-27137</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.19-27137</ArticleId><ArticleId IdType="pmc">PMC6779064</ArticleId><ArticleId IdType="pubmed">31560762</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore-Dotson JM, Beckman JJ, Mazade RE, Hoon M, Bernstein AS, Romero-Aleshire MJ, et al. Early retinal neuronal dysfunction in diabetic mice: Reduced light-evoked inhibition increases rod pathway signaling. Investigative Ophthalmology and Visual Science. 2016;57: 1418&#x2013;1430. doi: 10.1167/iovs.15-17999</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.15-17999</ArticleId><ArticleId IdType="pmc">PMC4819579</ArticleId><ArticleId IdType="pubmed">27028063</ArticleId></ArticleIdList></Reference><Reference><Citation>Castilho &#xc1;, Madsen E, Ambr&#xf3;sio AF, Veruki ML, Hartveit E. Diabetic hyperglycemia reduces Ca 2+ permeability of extrasynaptic AMPA receptors in AII amacrine cells. Journal of Neurophysiology. 2015;114: 1545&#x2013;1553. doi: 10.1152/jn.00295.2015</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00295.2015</ArticleId><ArticleId IdType="pmc">PMC4561628</ArticleId><ArticleId IdType="pubmed">26156384</ArticleId></ArticleIdList></Reference><Reference><Citation>Castilho &#xc1;, Ambr&#xf3;sio AF, Hartveit E, Veruki ML. Disruption of a neural microcircuit in the rod pathway of the mammalian retina by diabetes mellitus. Journal of Neuroscience. 2015;35: 5422&#x2013;5433. doi: 10.1523/JNEUROSCI.5285-14.2015</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5285-14.2015</ArticleId><ArticleId IdType="pmc">PMC6705407</ArticleId><ArticleId IdType="pubmed">25834065</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J, Wang L, Weng S-J, Yang X-L, Zhang D-Q, Zhong Y-M. Hyperactivity of ON-Type Retinal Ganglion Cells in Streptozotocin-Induced Diabetic Mice. Barnes S, editor. PLoS ONE. 2013;8: e76049. doi: 10.1371/journal.pone.0076049</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0076049</ArticleId><ArticleId IdType="pmc">PMC3777880</ArticleId><ArticleId IdType="pubmed">24069457</ArticleId></ArticleIdList></Reference><Reference><Citation>Archana R, Rajalakshmi T, Vijay Sai P. Non-invasive technique to detect diabetic retinopathy based on Electrooculography signal using machine learning classifiers. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine. 2022; 095441192210854. doi: 10.1177/09544119221085422</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09544119221085422</ArticleId><ArticleId IdType="pubmed">35337232</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainio-Theberge S, Wolff A, Northoff G. Dynamic relationships between spontaneous and evoked electrophysiological activity. Communications Biology. 2021;4: 1&#x2013;17. doi: 10.1038/s42003-021-02240-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02240-9</ArticleId><ArticleId IdType="pmc">PMC8206204</ArticleId><ArticleId IdType="pubmed">34131279</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan FL, Xiong J, Li M, Wang G. On Interpretability of Artificial Neural Networks: A Survey. IEEE Transactions on Radiation and Plasma Medical Sciences. 2021;5: 741&#x2013;760. doi: 10.1109/trpms.2021.3066428</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/trpms.2021.3066428</ArticleId><ArticleId IdType="pmc">PMC9105427</ArticleId><ArticleId IdType="pubmed">35573928</ArticleId></ArticleIdList></Reference><Reference><Citation>Scuderi G, Troiani E, Minnella AM. Gut Microbiome in Retina Health: The Crucial Role of the Gut-Retina Axis. Frontiers in Microbiology. Frontiers Media S.A.; 2022. p. 4246. doi: 10.3389/fmicb.2021.726792</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.726792</ArticleId><ArticleId IdType="pmc">PMC8795667</ArticleId><ArticleId IdType="pubmed">35095780</ArticleId></ArticleIdList></Reference><Reference><Citation>Ting DSW, Cheung CYL, Lim G, Tan GSW, Quang ND, Gan A, et al. Development and validation of a deep learning system for diabetic retinopathy and related eye diseases using retinal images from multiethnic populations with diabetes. JAMA&#x2014;Journal of the American Medical Association. 2017;318: 2211&#x2013;2223. doi: 10.1001/jama.2017.18152</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.18152</ArticleId><ArticleId IdType="pmc">PMC5820739</ArticleId><ArticleId IdType="pubmed">29234807</ArticleId></ArticleIdList></Reference><Reference><Citation>FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems | FDA. [cited 26 May 2022]. Available: https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-artificial-intelligence-based-device-detect-certain-diabetes-related-eye</Citation></Reference><Reference><Citation>Burke HB. The power of prediction. Cancer. Cancer; 2008. pp. 890&#x2013;892. doi: 10.1002/cncr.23675</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.23675</ArticleId><ArticleId IdType="pubmed">18615664</ArticleId></ArticleIdList></Reference><Reference><Citation>Gravina R, Alinia P, Ghasemzadeh H, Fortino G. Multi-sensor fusion in body sensor networks: State-of-the-art and research challenges. Information Fusion. 2017;35: 1339&#x2013;1351. doi: 10.1016/j.inffus.2016.09.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.inffus.2016.09.005</ArticleId></ArticleIdList></Reference><Reference><Citation>White NH, Pan Q, Knowler WC, Schroeder EB, Dabelea D, Chew EY, et al. The Effect of Interventions to Prevent Type 2 Diabetes on the Development of Diabetic Retinopathy: The DPP/DPPOS Experience. Diabetes Care. 2022. [cited 30 May 2022]. doi: 10.2337/dc21-2417</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc21-2417</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison WW, Bearse MA, Ng JS, Jewell NP, Barez S, Burger D, et al. Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes. Investigative Ophthalmology and Visual Science. 2011;52: 772&#x2013;777. doi: 10.1167/iovs.10-5931</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.10-5931</ArticleId><ArticleId IdType="pmc">PMC3053106</ArticleId><ArticleId IdType="pubmed">20926810</ArticleId></ArticleIdList></Reference><Reference><Citation>BEST (Biomarkers, EndpointS, and other Tools) Resource [Internet]&#x2014;PubMed. [cited 25 May 2022]. Available: https://pubmed.ncbi.nlm.nih.gov/27010052/</Citation></Reference><Reference><Citation>Burke HB. Predicting Clinical Outcomes Using Molecular Biomarkers. Biomarkers in Cancer. 2016;8: BIC.S33380. doi: 10.4137/BIC.S33380</Citation><ArticleIdList><ArticleId IdType="doi">10.4137/BIC.S33380</ArticleId><ArticleId IdType="pmc">PMC4896533</ArticleId><ArticleId IdType="pubmed">27279751</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachdeva MM. Retinal Neurodegeneration in Diabetes: an Emerging Concept in Diabetic Retinopathy. Current Diabetes Reports. Springer; 2021. doi: 10.1007/s11892-021-01428-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-021-01428-x</ArticleId><ArticleId IdType="pmc">PMC8668853</ArticleId><ArticleId IdType="pubmed">34902066</ArticleId></ArticleIdList></Reference><Reference><Citation>The increasing potential of electroretinography in ophthalmic diagnostics. [cited 30 May 2022]. Available: https://europe.ophthalmologytimes.com/view/the-increasing-potential-of-electroretinography-in-ophthalmic-diagnostics</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">34479753</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2013-2514</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2021</Year><Month>Aug</Month><Day>31</Day></PubDate></JournalIssue><Title>Nefrologia</Title><ISOAbbreviation>Nefrologia (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Interaction between the stage of chronic kidney disease and diabetes mellitus as factors associated with mortality in chronic kidney disease patients: An external cohort study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0211-6995(21)00159-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nefro.2021.04.012</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Diabetic kidney disease is the main cause of chronic kidney disease (CKD) worldwide. Both CKD and diabetes mellitus (DMT2) are important risk factors for mortality. However, it is still unknown if the risk of death is modified by the simultaneous presence of these diseases.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the presence of an interaction between DMT2 and CKD for mortality in a representative population of a Latin American country.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">It is an analytical cohort study of patients with CKD, who were followed for 4 years (between 2004 and 2009). We calculated the incidence rate, progression, survival (using Kaplan-Meier curves), interaction (on the additive and multiplicative scales) and impact of the different stages of CKD in patients with and without DMT2 (using a cox proportional hazards model).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In this population of 5663 individuals, both DMT2 and CKD are risk factors for mortality (P &lt; 0.001). We found a statistically significant difference in mortality between individuals with and without DMT2, who also had CKD stages 3 - 4 - 5 (Log-rank P = 0.0076). Additionally, we found a statistically significant interaction for mortality in both the additive and multiplicative scales between DMT2 and CKD (P = 0.005). DMT2 was found to be a risk factor for mortality (Hazard Ratio 1.61 P &lt; 0.001), but in individuals with DMT2, the only risks significantly associated with mortality, were age, dyslipidemia and nephroprotective drugs. CONCLUSI&#xf3;N: The interaction between CKD and DMT2 negatively modifies the risk of death of both diseases. This means that when the two diseases are present, the risk of mortality is lower than expected.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Sociedad Espa&#xf1;ola de Nefrolog&#xed;a. Published by Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Villegas Sierra</LastName><ForeName>Laura E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad de Antioquia, Medell&#xed;n, Colombia. Electronic address: laureelisa.villegas@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buritic&#xe1; Agudelo</LastName><ForeName>Melisa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad de Antioquia, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yepes Delgado</LastName><ForeName>Carlos Enrique</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad de Antioquia, Medell&#xed;n, Colombia; Unidad de Investigaciones, Hospital Pablo Tob&#xf3;n Uribe, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montoya Jaramillo</LastName><ForeName>Yanett Marcela</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad de Antioquia, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaimes Barragan</LastName><ForeName>Fabi&#xe1;n</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad de Antioquia, Medell&#xed;n, Colombia; Hospital Universitario San Vicente Fundaci&#xf3;n, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Interacci&#xf3;n entre el estadio de la enfermedad renal cr&#xf3;nica y la diabetes mellitus como factores asociados con mortalidad en pacientes con enfermedad renal cr&#xf3;nica: un estudio de cohortes externas.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Nefrologia (Engl Ed)</MedlineTA><NlmUniqueID>101778581</NlmUniqueID><ISSNLinking>2013-2514</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiovascular risk factors</Keyword><Keyword MajorTopicYN="N">Chronic kidney disease</Keyword><Keyword MajorTopicYN="N">Diabetes mellitus</Keyword><Keyword MajorTopicYN="N">Enfermedad renal cr&#xf3;nica</Keyword><Keyword MajorTopicYN="N">Factores de riesgo cardiovascular</Keyword><Keyword MajorTopicYN="N">Mortalidad</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>4</Day><Hour>5</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34479753</ArticleId><ArticleId IdType="doi">10.1016/j.nefro.2021.04.012</ArticleId><ArticleId IdType="pii">S0211-6995(21)00159-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32952169</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1665-1731</ISSN><JournalIssue CitedMedium="Internet"><Volume>90</Volume><Issue>3</Issue><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Archivos de cardiologia de Mexico</Title><ISOAbbreviation>Arch Cardiol Mex</ISOAbbreviation></Journal><ArticleTitle>Differential characteristics of the typical and atypical advanced interatrial block.</ArticleTitle><Pagination><StartPage>266</StartPage><EndPage>273</EndPage><MedlinePgn>266-273</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24875/ACM.20000240</ELocationID><Abstract><AbstractText Label="OBJETIVO">Se denomina bloqueo interauricular avanzado (BIA) a la existencia de una onda P &#x2265; 120 ms y bif&#xe1;sica +/- en las derivaciones inferiores (II-III-VF) del electrocardiograma (ECG) de superficie, el cual constituye un factor predictivo significativo del desarrollo de fibrilaci&#xf3;n auricular. En fecha reciente se han descrito cuatro patrones de BIA at&#xed;picos (BIA-At) con base en la morfolog&#xed;a y la duraci&#xf3;n de la onda P, sin conocer si comparten patogenia y caracter&#xed;sticas cl&#xed;nicas similares.</AbstractText><AbstractText Label="M&#xc9;TODO">Estudio observacional, descriptivo y retrospectivo de pacientes, visitados en el Servicio de Cardiolog&#xed;a, en ritmo sinusal y con BIA. Las variables analizadas se obtuvieron de la historia cl&#xed;nica informatizada. El an&#xe1;lisis de la onda P se efectu&#xf3; al aumentar el tama&#xf1;o del electrocardiograma y mediante calipers electr&#xf3;nicos. El an&#xe1;lisis estad&#xed;stico se realiz&#xf3; con SPSS 19.0, con nivel de significaci&#xf3;n de p &lt; 0.05.</AbstractText><AbstractText Label="RESULTADOS">Se incluy&#xf3; a 75 pacientes con media de edad de 74.4 &#xb1; 11.7 a&#xf1;os, con 62.7% de varones. Se compararon los grupos de pacientes con BIA t&#xed;pico (BIA-T) y BIA-At. El primero se relacion&#xf3; con la existencia de diabetes mellitus (p = 0.001), enfermedad renal cr&#xf3;nica estadio &#x2265; 3 (p = 0.036), bloqueo auriculoventricular (p = 0.006) y una menor fracci&#xf3;n de expulsi&#xf3;n ventricular media (p = 0.025); no hubo diferencias respecto de la prevalencia de fibrilaci&#xf3;n auricular/fl&#xfa;ter o accidente cerebrovascular. S&#xf3;lo la diabetes se acompa&#xf1;&#xf3; de riesgo de ser un BIA-T (OR: 6.4; p = 0.002; IC 95%: 2.0-21.1).</AbstractText><AbstractText Label="CONCLUSIONES">La diabetes mellitus constituye el &#xfa;nico factor de riesgo de que un BIA sea t&#xed;pico. Los pacientes con BIA-T y BIA-At presentan similar prevalencia de fibrilaci&#xf3;n auricular y accidente cerebrovascular, por lo que son objeto de un mismo tratamiento cl&#xed;nico.</AbstractText><AbstractText Label="OBJECTIVE">It is called advanced interatrial block (IAB) to the existence of a P wave &#x2265; 120 ms and biphasic &#xb1; in the lower leads II-III-VF of the surface electrocardiogram (ECG), which constitutes a significant predictive factor for the development of atrial fibrillation. Recently, four patterns of atypical aIAB (At-IAB) have been described based on the morphology and duration of the P wave, but it&#x2019;s unknown if they share the same pathogenesis and clinical characteristics.</AbstractText><AbstractText Label="METHOD">An observational, descriptive and retrospective study was performed with patients, visited in cardiology, who have a sinus rhythm and with aIAB. The analyzed variables were obtained from the computerized clinical history. The analysis of the P wave was made by increasing the size of the ECG and by electronic calipers. Statistical analysis was performed with SPSS 19.0; level of significance: p &lt; 0.05.</AbstractText><AbstractText Label="RESULTS">A total of 75 patients with an average age of 74.4 &#xb1; 11.7 years and with a 62.7% males, were included. It was compared the group of patients with typical aIAB (T-aIAB) and with At-aIAB. The first one was associated with the existence of diabetes mellitus (p = 0.001), chronic kidney disease stage &#x2265; 3 (p = 0.036), atrioventricular block (p = 0.006) and a lower mean ventricular ejection fraction (p = 0.025); there were no differences regarding the prevalence of atrial fibrillation/flutter or stroke. Only diabetes was associated with the risk of T-aIAB (odds ratio: 6.4; p = 0.002; 95% confidence interval: 2.0-21.1).</AbstractText><AbstractText Label="CONCLUSIONS">Diabetes mellitus is the only risk factor for an aIAB to be typical. Patients with T-aIAB and At-aIAB have a similar prevalence of atrial fibrillation and stroke, so they must follow the same clinical management.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2020 Permanyer.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gentille-Lorente</LastName><ForeName>Delicia</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Servicio de Cardiolog&#xed;a. Hospital de Tortosa Verge de la Cinta, IISPV/Tortosa, Tarragona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salvad&#xf3;-Usach</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Servicio de Anatom&#xed;a Patol&#xf3;gica. Hospital de Tortosa Verge de la Cinta, IISPV/Tortosa, Tarragona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><VernacularTitle>Caracter&#xed;sticas diferenciales del bloqueo interauricular avanzado t&#xed;pico y at&#xed;pico.</VernacularTitle></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Arch Cardiol Mex</MedlineTA><NlmUniqueID>101126728</NlmUniqueID><ISSNLinking>1665-1731</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054537" MajorTopicYN="N">Atrioventricular Block</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="Y">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000074021" MajorTopicYN="N">Interatrial Block</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Advanced Interatrial Block</Keyword><Keyword MajorTopicYN="N">Atrial Fibrillation</Keyword><Keyword MajorTopicYN="N">Bachmann&#x2019;s Block</Keyword><Keyword MajorTopicYN="N">Bay&#xe9;s&#x2019;</Keyword><Keyword MajorTopicYN="N">Bloqueo de Bachmann</Keyword><Keyword MajorTopicYN="N">Bloqueo interauricular</Keyword><Keyword MajorTopicYN="N">Bloqueo interauricular avanzado</Keyword><Keyword MajorTopicYN="N">Bloqueo interauricular de tercer grado</Keyword><Keyword MajorTopicYN="N">Fibrilaci&#xf3;n auricular</Keyword><Keyword MajorTopicYN="N">Interatrial block</Keyword><Keyword MajorTopicYN="N">Syndrome</Keyword><Keyword MajorTopicYN="N">S&#xed;ndrome de Bay&#xe9;s</Keyword><Keyword MajorTopicYN="N">Third Degree Interatrial Block</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32952169</ArticleId><ArticleId IdType="doi">10.24875/ACM.20000240</ArticleId><ArticleId IdType="pii">j90/3/266</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32384406</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>30</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Survival Benefit for Metformin Through Better Tumor Response by Neoadjuvant Concurrent Chemoradiotherapy in Rectal Cancer.</ArticleTitle><Pagination><StartPage>758</StartPage><EndPage>768</EndPage><MedlinePgn>758-768</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000001624</ELocationID><Abstract><AbstractText Label="BACKGROUND">Metformin may reduce cancer risk and mortality and improve radiotherapy responses in several malignancies.</AbstractText><AbstractText Label="OBJECTIVE">This study aimed to compare tumor responses and prognoses of metformin and nonmetformin groups of diabetic patients receiving neoadjuvant concurrent chemoradiotherapy for rectal cancer.</AbstractText><AbstractText Label="DESIGN">This is a retrospective study.</AbstractText><AbstractText Label="SETTING">This study was conducted at a single institution in the Republic of Korea.</AbstractText><AbstractText Label="PATIENTS">Between January 2000 and November 2017, 104 patients with rectal cancer who were taking diabetes medication and treated with neoadjuvant concurrent chemoradiotherapy followed by radical surgery were reviewed. Patients were divided into those taking (n = 62) and not taking metformin (n = 42). Tumor responses, survival, and other outcomes were analyzed.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">Tumor response, rectal cancer-specific survival, and disease-free survival rates were measured.</AbstractText><AbstractText Label="RESULTS">Tumor regression grade (p = 0.002), pathological complete response (p = 0.037), and N downstaging (p &lt; 0.001) after neoadjuvant concurrent chemoradiotherapy were significantly higher in the metformin group than in the nonmetformin group. In analysis of cancer-specific mortality, metformin use, differentiation (well, moderate vs poor), pathological Union for International Cancer Control stage (3 vs 1-2), ypN stage (1-2 vs 0), and N downstaging (HR, 0.256 (95% CI, 0.082-0.794), p = 0.018; HR, 0.147 (95% CI, 0.031-0.697), p = 0.016; HR, 3.693 (95% CI, 1.283-10.635), p = 0.015; HR, 3.181 (95% CI, 1.155-8.759), p = 0.025, and HR, 0.175 (95% CI, 0.040-0.769), p = 0.021) were significant factors related to mortality in diabetic patients with rectal cancer. In addition, in the multivariate analysis of cancer recurrence, the interaction between metformin use and lymph node downstaging was a significant predictive factor (HR, 0.222 (95% CI, 0.077-0.639); p = 0.005).</AbstractText><AbstractText Label="LIMITATIONS">This was a small retrospective study conducted at a single institution.</AbstractText><AbstractText Label="CONCLUSIONS">Metformin use was associated with better tumor responses and cancer-specific survival, as well as a lower risk of cancer recurrence, in patients with diabetes mellitus who had lymph node downstaging after neoadjuvant concurrent chemoradiotherapy in rectal cancer. See Video Abstract at http://links.lww.com/DCR/B185. BENEFICIO EN SUPERVIVENCIA CON METFORMINA A TRAV&#xc9;S DE UNA MEJOR RESPUESTA TUMORAL CON QUIMIORRADIOTERAPIA CONCURRENTE NEOADYUVANTE EN C&#xc1;NCER RECTAL: La metformina puede reducir el riesgo de c&#xe1;ncer y la mortalidad y mejorar las respuestas a la radioterapia en varios tumores malignos.Comparar las respuestas tumorales y los pron&#xf3;sticos de los grupos con metformina y sin metformina de pacientes diab&#xe9;ticos que reciben quimiorradioterapia concurrente neoadyuvante para c&#xe1;ncer de recto.Estudio retrospectivo.Instituci&#xf3;n &#xfa;nica en la Rep&#xfa;blica de Corea.Se revisaron 104 pacientes entre enero de 2000 y noviembre de 2017, con c&#xe1;ncer rectal que tomaban medicamentos para diabetes y que fueron tratados con quimiorradioterapia concurrente neoadyuvante seguida de cirug&#xed;a radical. Los pacientes se dividieron en aquellos que tomaban (n = 62) y los que no tomaban metformina (n = 42). Se analizaron las respuestas tumorales, la supervivencia y otros resultados.Se midieron las tasas de la respuesta tumoral, la supervivencia espec&#xed;fica de c&#xe1;ncer rectal y de la supervivencia libre de enfermedad.El grado de regresi&#xf3;n tumoral (p = 0.002), la remisi&#xf3;n patol&#xf3;gica completa (p = 0.037) y la reducci&#xf3;n de la etapa N (p &lt; 0.001) despu&#xe9;s de la quimiorradioterapia concurrente neoadyuvante fueron significativamente mayores en el grupo de metformina que en el grupo sin metformina. En el an&#xe1;lisis de la mortalidad espec&#xed;fica por c&#xe1;ncer, el uso de metformina, la diferenciaci&#xf3;n (bien, moderada vs pobre), el estadio patol&#xf3;gico UICC (3 vs 1-2), el estadio ypN (1-2 vs 0) y la disminuci&#xf3;n de la etapa N (hazard ratios [intervalos de confianza 95%]: 0.256 [0.082-0.794], p = 0.018; 0.147 [0.031-0.697], p = 0.016; 3.693 [1.283-10.635], p = 0.015; 3.181 [1.155-8.759], p = 0.025 y 0.175 [0.040-0.769], p = 0.021, respectivamente) fueron factores significativos relacionados con la mortalidad en pacientes diab&#xe9;ticos con c&#xe1;ncer rectal. Adicionalmente, en el an&#xe1;lisis multivariado de la recurrencia del c&#xe1;ncer, la interacci&#xf3;n entre el uso de metformina y la disminuci&#xf3;n de la etapa ganglionar (N) fue un factor predictivo significativo (hazard ratios [intervalos de confianza del 95%]: 0.222 [0.077-0.639]; p = 0.005).Este fue un estudio retrospectivo peque&#xf1;o realizado en un solo instituto.El uso de metformina se asoci&#xf3; con mejores respuestas tumorales y supervivencia espec&#xed;fica de c&#xe1;ncer, as&#xed; como un menor riesgo de recurrencia del c&#xe1;ncer, en pacientes con disminuci&#xf3;n de la etapa ganglionar (N) despu&#xe9;s de quimiorradioterapia concurrente neoadyuvante en pacientes con c&#xe1;ncer rectal y diabetes. Consulte Video Resumen en http://links.lww.com/DCR/B185. (Traducci&#xf3;n-Dr. Jorge Silva Velazco).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jung Min</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jung Won</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jin Ha</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Ye Hyun</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Soo Jung</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheon</LastName><ForeName>Jae Hee</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Won Ho</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Tae Il</ForeName><Initials>TI</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yonsei Cancer Prevention Center, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>9100L32L2N</RegistryNumber><NameOfSubstance UI="D008687">Metformin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Dis Colon Rectum. 2020 Jun;63(6):718-719. doi: 10.1097/DCR.0000000000001669.</RefSource><PMID Version="1">32384400</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059248" MajorTopicYN="N">Chemoradiotherapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008198" MajorTopicYN="N">Lymph Nodes</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008687" MajorTopicYN="N">Metformin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020360" MajorTopicYN="N">Neoadjuvant Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012004" MajorTopicYN="N">Rectal Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32384406</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000001624</ArticleId><ArticleId IdType="pii">00003453-202006000-00008</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McCarthy K, Pearson K, Fulton R, Hewitt J. Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer. Cochrane Database Syst Rev. 2012;12:CD008368.</Citation></Reference><Reference><Citation>Fokas E, Liersch T, Fietkau R, et al. Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial. J Clin Oncol. 2014;32:1554&#x2013;1562.</Citation></Reference><Reference><Citation>Gavioli M, Luppi G, Losi L, et al. Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer. Dis Colon Rectum. 2005;48:1851&#x2013;1857.</Citation></Reference><Reference><Citation>Garajov&#xe1; I, Di Girolamo S, de Rosa F, et al. Neoadjuvant treatment in rectal cancer: actual status. Chemother Res Pract. 2011;2011:839742.</Citation></Reference><Reference><Citation>Roh MS, Colangelo LH, O&#x2019;Connell MJ, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol. 2009;27:5124&#x2013;5130.</Citation></Reference><Reference><Citation>Caudle AS, Kim HJ, Tepper JE, et al. Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer. Ann Surg Oncol. 2008;15:1931&#x2013;1936.</Citation></Reference><Reference><Citation>Mills KT, Bellows CF, Hoffman AE, Kelly TN, Gagliardi G. Diabetes mellitus and colorectal cancer prognosis: a meta-analysis. Dis Colon Rectum. 2013;56:1304&#x2013;1319.</Citation></Reference><Reference><Citation>Pernicova I, Korbonits M. Metformin&#x2013;mode of action and clinical implications for diabetes and cancer. Nat Rev Endocrinol. 2014;10:143&#x2013;156.</Citation></Reference><Reference><Citation>DeFronzo RA, Barzilai N, Simonson DC. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. J Clin Endocrinol Metab. 1991;73:1294&#x2013;1301.</Citation></Reference><Reference><Citation>Jackson RA, Hawa MI, Jaspan JB, et al. Mechanism of metformin action in non-insulin-dependent diabetes. Diabetes. 1987;36:632&#x2013;640.</Citation></Reference><Reference><Citation>Landman GW, Kleefstra N, van Hateren KJ, Groenier KH, Gans RO, Bilo HJ. Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care. 2010;33:322&#x2013;326.</Citation></Reference><Reference><Citation>Libby G, Donnelly LA, Donnan PT, Alessi DR, Morris AD, Evans JM. New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care. 2009;32:1620&#x2013;1625.</Citation></Reference><Reference><Citation>Zhang ZJ, Zheng ZJ, Kan H, et al. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis. Diabetes Care. 2011;34:2323&#x2013;2328.</Citation></Reference><Reference><Citation>Mei ZB, Zhang ZJ, Liu CY, et al. Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis. PLoS One. 2014;9:e91818.</Citation></Reference><Reference><Citation>Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD. Metformin and reduced risk of cancer in diabetic patients. BMJ. 2005;330:1304&#x2013;1305.</Citation></Reference><Reference><Citation>Lee JH, Kim TI, Jeon SM, Hong SP, Cheon JH, Kim WH. The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus. Int J Cancer. 2012;131:752&#x2013;759.</Citation></Reference><Reference><Citation>Expert Consultation WHO; WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157&#x2013;163.</Citation></Reference><Reference><Citation>KSAR Study Group for Rectal Cancer. Essential items for structured reporting of rectal cancer MRI: 2016 consensus recommendation from the Korean Society of Abdominal Radiology. Korean J Radiol. 2017;18:132&#x2013;151.</Citation></Reference><Reference><Citation>Siddiqui MR, Bhoday J, Battersby NJ, et al. Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales. World J Gastroenterol. 2016;22:8414&#x2013;8434.</Citation></Reference><Reference><Citation>Kim DJ, Kim JH, Lim JS, et al. Restaging of rectal cancer with MR imaging after concurrent chemotherapy and radiation therapy. Radiographics. 2010;30:503&#x2013;516.</Citation></Reference><Reference><Citation>Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373&#x2013;1379.</Citation></Reference><Reference><Citation>Lee JH, Jeon SM, Hong SP, Cheon JH, Kim TI, Kim WH. Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer. Dig Liver Dis. 2012;44:1042&#x2013;1047.</Citation></Reference><Reference><Citation>Onitilo AA, Engel JM, Glurich I, Stankowski RV, Williams GM, Doi SA. Diabetes and cancer II: role of diabetes medications and influence of shared risk factors. Cancer Causes Control. 2012;23:991&#x2013;1008.</Citation></Reference><Reference><Citation>Chang CH, Lin JW, Wu LC, Lai MS, Chuang LM, Chan KA. Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus. Hepatology. 2012;55:1462&#x2013;1472.</Citation></Reference><Reference><Citation>Tobi M, Yang Y-X, Antaki F, Rambus M, Lawson MJ. Mo1914 thiazolidinediones but not metformin significantly reduce colorectal neoplastic lesions in diabetics at risk for colorectal neoplasia. Gastroenterology. 2014;146:S690.</Citation></Reference><Reference><Citation>Tseng YH, Tsan YT, Chan WC, Sheu WH, Chen PC. Use of an &#x3b1;-glucosidase inhibitor and the risk of colorectal cancer in patients with diabetes: a nationwide, population-based cohort study. Diabetes Care. 2015;38:2068&#x2013;2074.</Citation></Reference><Reference><Citation>Skinner HD, Crane CH, Garrett CR, et al. Metformin use and improved response to therapy in rectal cancer. Cancer Med. 2013;2:99&#x2013;107.</Citation></Reference><Reference><Citation>Oh BY, Park YA, Huh JW, et al. Metformin enhances the response to radiotherapy in diabetic patients with rectal cancer. J Cancer Res Clin Oncol. 2016;142:1377&#x2013;1385.</Citation></Reference><Reference><Citation>Zanders MM, van Herk-Sukel MP, Vissers PA, Herings RM, Haak HR, van de Poll-Franse LV. Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another? Br J Cancer. 2015;113:403&#x2013;410.</Citation></Reference><Reference><Citation>Rega D, Pecori B, Scala D, et al. Evaluation of tumor response after short-course radiotherapy and delayed surgery for rectal cancer. PLoS One. 2016;11:e0160732.</Citation></Reference><Reference><Citation>Magri KD, Bin FC, Formiga FB, et al. Impact of neoadjuvant therapy in downstaging of lower rectal adenocarcinoma and the role of pelvic magnetic resonance in staging. Rev Col Bras Cir. 2016;43:102&#x2013;109.</Citation></Reference><Reference><Citation>Sun YS, Zhang XP, Tang L, et al. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology. 2010;254:170&#x2013;178.</Citation></Reference><Reference><Citation>Koeberle D, Burkhard R, von Moos R, et al. Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer. Br J Cancer. 2008;98:1204&#x2013;1209.</Citation></Reference><Reference><Citation>Das P, Skibber JM, Rodriguez-Bigas MA, et al. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol. 2006;29:219&#x2013;224.</Citation></Reference><Reference><Citation>Smith KD, Tan D, Das P, et al. Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation. Ann Surg. 2010;251:261&#x2013;264.</Citation></Reference><Reference><Citation>Park IJ, You YN, Agarwal A, et al. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol. 2012;30:1770&#x2013;1776.</Citation></Reference><Reference><Citation>Collette L, Bosset JF, den Dulk M, et al.; European Organisation for Research and Treatment of Cancer Radiation Oncology Group. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group. J Clin Oncol. 2007;25:4379&#x2013;4386.</Citation></Reference><Reference><Citation>Fietkau R, Barten M, Klautke G, et al. Postoperative chemotherapy may not be necessary for patients with ypN0-category after neoadjuvant chemoradiotherapy of rectal cancer. Dis Colon Rectum. 2006;49:1284&#x2013;1292.</Citation></Reference><Reference><Citation>Das P, Skibber JM, Rodriguez-Bigas MA, et al. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer. 2007;109:1750&#x2013;1755.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>